8YY fundamentals
An in-depth look to BIOLIDICS operating, investing, and financing activities
8YY free cash flow for Q3 24 is -1.16 M SGD. For 2023, 8YY free cash flow was -1.97 M SGD and operating cash flow was -1.97 M SGD.
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SGD
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM